CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-14 | Weldon Steven W Former Officer and Director | Sale | −46,300 | $0.29 | $13K | 4,253,700 |
| 2020-12-11 | Weldon Steven W Former Officer and Director | Sale | −50,000 | $0.25 | $13K | 4,450,000 |
| 2020-12-11 | Weldon Steven W Former Officer and Director | Sale | −50,000 | $0.26 | $13K | 4,400,000 |
| 2020-11-16 | Wendel Bruce Director | Purchase | +3,268 | $3.14 | $10K | 3,268 |
| 2020-06-02 | Cataldo Tony CEO | Sale | −4,234,320 | $0.00 | $4K | 6,500,000 |
| 2020-05-13 | Weldon Steven W CFO | Sale | −2,269,708 | $0.00 | $2K | 4,500,000 |
| 2019-08-14 | Cataldo Tony CEO | Grant or award | +7,000,000 | 10,734,320 | ||
| 2019-08-14 | Weldon Steven W CFO | Grant or award | +4,500,000 | 6,769,707 | ||
| 2019-02-06 | Cataldo Tony Director | Sale | −800,000 | $0.00 | $800 | 4,029,600 |
| 2019-02-01 | Urbanski Raymond W. CEO | Sale | −176,980 | $0.00 | $177 | 1,351,918 |
| 2017-11-02 | Cataldo Tony Executive Chairman | Gift | −200,000 | 4,943,029 | ||
| 2017-11-02 | Cataldo Tony Executive Chairman | Gift | −100,000 | 4,843,029 | ||
| 2017-11-02 | Cataldo Tony Executive Chairman | Gift | −3,000,000 | 1,843,029 | ||
| 2017-09-01 | Cataldo Tony Executive Chairman | Grant or award | +5,129,660 | 5,143,029 | ||
| 2017-09-01 | Weldon Steven W CFO | Grant or award | +2,566,835 | 2,568,840 | ||
| 2016-04-05 | BRISTOL INVESTMENT FUND LTD 10% owner | Other acquisition | +250,000 | 463,806 | ||
| 2016-04-04 | BRISTOL INVESTMENT FUND LTD 10% owner | Sale | −675,000 | $303,750.00 | $205.0B | 1,525,472 |
| 2012-03-01 | Saloff David CEO, Chairman of the Board | Grant or award · Common Stock Option | +26,334,193 | $0.04 | $1.1M | 27,650,684 |
| 2011-08-31 | Saloff David Chief Executive Officer | Grant or award · Common Stock Option | +538,713 | $0.05 | $29K | 1,316,491 |
| 2011-05-20 | DUBE ANSHUMAN Director | Purchase · 12% Convertible Debenture due 2012 | +0 | $25,000.00 | $0 | 250,000 |
Page 4 of 9 · 164 trades